International Journal of Antimicrobial Agents

The International Journal of Antimicrobial Agents is a monthly journal published by Elsevier on behalf of the International Society of Antimicrobial Chemotherapy, founded in 1991, with a 2025 impact factor of about 5（International Journal of Antimicrobial Agents）是由（Elsevier）代表国际抗微生物化学治疗学会（ISAC）出版的月刊，1991 年创办，2025 年影响因子约为 5。

Scope

• The journal reports the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents against viruses, parasites, bacteria and fungi该刊报道针对病毒、寄生虫、细菌与真菌的各类抗微生物药物的物理、药理、体外与临床性质。
• It publishes authoritative reviews of antimicrobial drugs, immunomodulators and immunotherapy发表抗微生物药物、免疫调节剂与免疫治疗方面的高权威综述。
• Antimicrobial resistance in hospitals and in the community is a central concern医院与社区中的抗微生物耐药问题是其核心关注点。
• Work on the discovery, development and clinical use of antimicrobial agents is covered涵盖抗微生物药物的发现、研发与临床应用。
• Both laboratory and clinical studies fall within its scope实验室研究与临床研究均在收稿范围之内。

History

• It was founded in 1991, evolving from the Antimicrobial Agents Annual该刊 1991 年创办，由（Antimicrobial Agents Annual）衍化而来。
• Print issues ceased with volume 48 in 2016, after which the journal became online-only纸质版于 2016 年第 48 卷后停刊，此后转为纯在线出版。
• It is published by Elsevier as the official journal of the International Society of Antimicrobial Chemotherapy该刊由（Elsevier）出版，是国际抗微生物化学治疗学会的官方期刊。
• It is a monthly publication with a 2025 impact factor of about 5该刊为月刊，2025 年影响因子约为 5。

Editors

• Jian Li of Monash University in Australia is the editor-in-chief现任主编为澳大利亚（Monash University）的 Jian Li。
• The journal maintains an international editorial board spanning antimicrobial chemotherapy and infectious diseases该刊编委会具国际性，覆盖抗微生物化学治疗与感染性疾病领域。
• It operates under a hybrid open access model该刊采用混合开放获取模式。
• Articles are peer reviewed before publication文章须经同行评审后发表。